Piramal Pharma Ltd
NSE:PPLPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
Tigers Realm Coal Ltd
ASX:TIG
|
AU |
|
Lenta Plc
LSE:LNTA
|
RU |
|
N
|
Neptis SA
WSE:YAN
|
PL |
|
S
|
Shinsung Delta Tech Co Ltd
KOSDAQ:065350
|
KR |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
C
|
Consorcio Ara SAB de CV
BMV:ARA
|
MX |
|
O
|
Olympic Circuit Technology Co Ltd
SSE:603920
|
CN |
|
D
|
DaedongGear
KOSDAQ:008830
|
KR |
|
T
|
Thai Union Group PCL
SET:TU
|
TH |
|
HCP Plastene Bulkpack Ltd
BSE:526717
|
IN |
|
Water Ways Technologies Inc
XTSX:WWT
|
CA |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
Bankruptcy Probability
Piramal Pharma Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Piramal Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
193.7B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Piramal Pharma Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Piramal Pharma Ltd has total debt of 34.2B INR. This includes both short-term (0 INR) and long-term (34.2B INR) debt.
You can find a full breakdown on its Balance Sheet.
